维普中文期刊产品整合服务
11篇 您的检索式:作者名="Veillard AS"
    题名 作者 年代 出处 被引量
1Cross-validation study of class Ⅲ beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials显示文摘Reiman T Lai R Veillard AS 2012Ann Oncol2012,23,1:1
2Serum 25-bydrox- yvitamin d: a predictor of macrovaseular and mierovascular com- plications in patients with type 2 diabetes 显示文摘Herrmann M Sullivan DR Veillard AS 2015Diabetes Care2015,38,3:1
3Cross-validation study of classⅢ beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials显示文摘Reiman T Lai R Veillard AS 2012Ann Oncol2012,23,1:1
4Phase 2 study of frontline bortezomib in patients with advanced non- small cell lung cancer显示文摘BESSE B PLANCHARD D VEILLARD AS et ol 2012Lung Cancer2012,76,1:1
5Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes 显示文摘Herrmann M Sullivan DR Veillard AS 2015Diabetes Care2015,38,3:1
6Plasma ho- mocysteine and the risk of venous thromboembolism insights from the FIELD study显示文摘Herrmann M Whiting MJ Veillard AS 2012Clin Chem Lab Med2012,50,12:1
7Cross-validation study of class Ⅲ beta-tubulin as a predictive marker for benefit from ad- juvant chemotherapy in resected non-small-cell lung cancer:anal- ysis of four randomized trials显示文摘Reiman T Lai R Veillard AS 2012Ann Oncol2012,23,1:1
8Serum 25 -- hydroxyvitamin D: a predictor of macrovascular and mi- crovascular complications in patients with type 2 diabetes 显示文摘Herrmann M Sullivan DR Veillard AS 2015Diabetes Care2015,38,3:1
9Cross-validation study of class llI beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials显示文摘Reiman T Lai R Veillard AS 2012Ann Oncol2012,23,1:1
10Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer显示文摘Besse B Planchard D Veillard AS 0,,01:1
11Serum 25- hydroxyvitamin D: a predictor of macrovascular and mierovascular complications in patients with type 2 diabetes 显示文摘Herrmann M Sullivan DR Veillard AS 2015Diabetes Care2015,38,3:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费